InsiderTrades

Form 4 for MGNX MACROGENICS INC

Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-15 · accession 0001125345-25-000031 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-19 2025-02-15 MGNX Smith Beth Ann VP, Ctrl, Treas S - Sale+OE $2.56 -423 9,532 -4% -$1,083
D 2025-02-19 2025-02-15 MGNX Smith Beth Ann VP, Ctrl, Treas M - OptEx $0.00 +1,095 9,955 +12% $0
D 2025-02-19 2025-02-15 MGNX Smith Beth Ann VP, Ctrl, Treas M - OptEx $0.00 -1,095 1,095 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-15 S D 423 $2.56 9,532 D — —
2 Common Common Stock 2025-02-15 M A 1,095 $0.00 9,955 D — — (F1) On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
3 Derivative Restricted Stock Unit 2025-02-15 M D 1,095 $0.00 1,095 D $0.00 · — to — 1,095 Common Stock (F1) On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.